Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 6.75
0.00 (0.00%)
At close: Dec 5, 2025
Renalytix Revenue
In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M USD with 30.43% growth. Renalytix had revenue of $1.25M in the quarter ending December 31, 2024, with 76.45% growth.
Revenue
$3.00M
Revenue Growth
+35.07%
P/S Ratio
13.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.50M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Renalytix News
- 2 months ago - AIM Market Roundup: Future Metals, Renalytix, Nativo Resources - The Armchair Trader
- 2 months ago - AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics - The Armchair Trader
- 9 months ago - Half Year 2025 Renalytix PLC Online Investor Presentation Transcript - GuruFocus
- 9 months ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Renalytix AI GAAP EPS of -$0.05, revenue of $1.25M; reaffirms outlook - Seeking Alpha
- 10 months ago - UBS Group AG Acquires Significant Stake in Renalytix PLC - GuruFocus
- 1 year ago - Renalytix AI reports Q1 results - Seeking Alpha
- 1 year ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire